Beverly Hills, CA1 Active Studies

Wet Age-Related Macular Degeneration Clinical Trials in Beverly Hills, CA

Find 1 actively recruiting wet age-related macular degeneration clinical trials in Beverly Hills, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
630
Enrolling

Recruiting Wet Age-Related Macular Degeneration Studies in Beverly Hills

About Wet Age-Related Macular Degeneration Clinical Trials in Beverly Hills

Wet age-related macular degeneration is the advanced form of AMD where abnormal blood vessels grow under the retina and leak fluid or blood. It can cause rapid vision loss if untreated. Treatment involves regular anti-VEGF injections that can stabilize or improve vision.

There are currently 1 wet age-related macular degeneration clinical trials recruiting participants in Beverly Hills, CA. These studies are seeking a combined 630 participants. Research is being sponsored by AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Wet Age-Related Macular Degeneration Clinical Trials in Beverly Hills — FAQ

Are there wet age-related macular degeneration clinical trials in Beverly Hills?

Yes, there are 1 wet age-related macular degeneration clinical trials currently recruiting in Beverly Hills, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Beverly Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beverly Hills research site will contact you about next steps.

Are clinical trials in Beverly Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beverly Hills studies also compensate for your time and travel.

What wet age-related macular degeneration treatments are being tested?

The 1 active trials in Beverly Hills are testing new therapies including novel drugs, biologics, and treatment approaches for wet age-related macular degeneration.

Data updated March 2, 2026 from ClinicalTrials.gov